Private Advisor Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
NA
Private Advisor Group's NVCR Position: Q2 2023 in Review
Private Advisor Group sold out of NovoCure (NVCR) in Q2 2023, closing a stake of 3,912 shares — an estimated $235K sold.
Private Advisor Group first reported a position in NVCR in Q3 2018 and held it in 18 quarters. The position peaked at $1.28M in Q2 2021. 267 funds tracked by Wall St. Rank hold NVCR as of Q2 2023.
- Private Advisor Group reported no remaining NovoCure position as of Q2 2023 after selling out during the quarter.
- Private Advisor Group sold 3,912 NovoCure shares in Q2 2023, an estimated $235K.
- Private Advisor Group first reported a position in NovoCure in Q3 2018 and held it in 18 quarters.
- Private Advisor Group's NovoCure position peaked at $1.28M in Q2 2021.
- 267 funds tracked by Wall St. Rank held NovoCure as of Q2 2023.
Based on Private Advisor Group's 13F filing for Q2 2023, filed 10 Aug 2023.